000			04536nam a22003975i 4500
999			_c392967 _d392967
001			392967
003			ES-MaUEC
005			20231202175404.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			110930s2012 xxu| fo |||| 0|eng d
020			_a9781617793370
024	7		_a10.1007/978-1-61779-337-0 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aQP606 .P76 _b2012 EB
245	0	0	_aKinase Inhibitors _bMethods and Protocols _cedited by Bernhard Kuster
250			_a1st edition 2012
264		1	_aTotowa, NJ _bHumana Press _c2012
300			_a1 recurso en línea (XI, 256 páginas) _b47 ilustraciones, 11 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Molecular Biology _x1940-6029 _v795
505	0		_aTargeting Cancer with Small Molecular Weight Kinase Inhibitors -- Small Molecule Protein and Lipid Kinase Inhibitors in Inflammation and Specific Models for their Evaluation -- Measuring the Activity of Leucine Rich Repeat Kinase 2 (LRRK2) - A Kinase Involved in Parkinson's Disease -- Measuring PI3K Lipid Kinase Activity -- A Fluorescence Polarization Assay for the Discovery of Inhibitors of the Polo-box Domain of Polo-like Kinase 1 -- Assessment of Hepatotoxicity Potential of Drug Candidate Molecules Including Kinase Inhibitors by Hepatocyte Imaging Assay Technology and Bile Flux Imaging Assay Technology -- Kinase Inhibitor Selectivity Profiling using Differential Scanning Fluorimetry -- Chemoproteomic Characterization of Protein Kinase Inhibitors using Immobilized ATP -- Proteome-wide identification of staurosporine-binding kinases using Capture Compound Mass Spectrometry -- Affinity Purification of Proteins Binding to Kinase Inhibitors Immobilised on Self Assembling Monolayers -- Kinase Inhibitor Profiling using Chemoproteomics -- Covalent Crosslinking of Kinases with Their Corresponding Peptide Substrates -- Receptor Tyrosine Kinase Inhibitor Profiling using Bead-based Multiplex Sandwich Immunoassays -- Monitoring Phosphoproteomic Response To Targeted Kinase Inhibitors Using Reverse-Phase Protein Microarrays -- Measuring Phosphorylation Specific Changes in Response to Kinase Inhibitors in Mammalian Cells Using Quantitative Proteomics -- Investigation of Acquired Resistance to EGFR-Targeted Therapies in Lung Cancer Using cDNA Microarrays.
520			_aProtein and lipid kinases are often the master regulators of cell signaling in eukaryotic systems. The human genome codes for more than 500 of these enzymes and their misregulation has been shown to be involved in the onset and progression of many diseases including cancer and inflammation. Therefore, small molecule kinase inhibitors have become important research tools for the elucidation of the many biological roles of kinases and their mechanisms of action. Kinase inhibitors thus also contribute significantly to the drug pipelines of the pharmaceutical and biotechnology industries and to the growing need to treat cancer and inflammation. In Kinase Inhibitors: Methods and Protocols, experts in kinase biology, drug discovery, and clinical research present a series of exemplary methods that can be used to address the many challenges facing scientists in the discovery and development of kinase inhibitors both for research and clinical use. Written in the highly successful Methods in Molecular Biology™ series format, chapters contain introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and accessible, Kinase Inhibitors: Methods and Protocols aims to provide scientists with modern and relevant methods to accelerate or strengthen their research and drug discovery programs through the utilization of these vital regulators.
988			_aSpringer_Protocols_2012
650		7	_2embne _9139861 _aProteínas
776	0	8	_iPrinted edition: _z9781617793363
776	0	8	_iPrinted edition: _z9781617793387
776	0	8	_iPrinted edition: _z9781493957576
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-61779-337-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b12/2023 _dz _ean _zSI